Reframing The Spectrum of Steatotic Liver Disease as a Dynamic Concept

Abstract

Section snippets

Data Availability

Not applicable

Author Contributions:

Zobair M. Younossi- study design, critical writing and editing of the manuscriptShira Zelber-Sagi- study design, critical writing and editing of the manuscriptAleksander Krag -study design, critical writing and editing of the manuscript

Funding

This letter was partially funded by the Global NASH and the Global Liver Councils, the Beatty Center for Liver and Obesity Research and the Center for Outcomes Research in Liver Disease

Declaration of Competing Interest

Zobair M. Younossi is a consultant or has received research funding from Intercept, Cymabay, Boehringer Ingelheim, Ipsen, Gilead Sciences, Inventiva, BMS, GSK, NovoNordisk, Siemens, Madridgal, Merck, Akero and Abbott. All other authors have no conflicts of interest to declare relevant for this manuscript